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Purpose: To evaluate the association of self-reported erectile function and endothelial function using the EndoPAT device.
Materials and Methods: We prospectively enrolled 76 men (age≥40 years) after obtaining a complete medical history and a 
self-reported questionnaire (International Index of Erectile Function-5 [IIEF-5], SEP Q2, Q3). Endothelial function was non- 
invasively measured with an EndoPAT 2000, recorded as the reactive hyperemia index (RHI), and analyzed according to the 
patients’ baseline characteristics.
Results: The mean patient age and IIEF-5 score were 62.50±8.56 years and 11.20±6.36, respectively. In comparing the RHI 
according to erectile dysfunction (ED) risk factors, the RHI was significantly lower in older subjects (p=0.004). There was no 
difference in the RHI according to age, body mass index, waist circumference, obesity, smoking habit, or other comorbidities. 
When the subjects were divided into four groups according to the severity of ED, no statistical differences in the RHI value were 
found among the groups. There was no difference in IIEF-5 according to the RHI when categorized according to the normal cutoff 
value or quartile ranges. The second subdomain of IIEF-5 (erection firmness) was significantly correlated with the RHI value 
(R=0.309, p=0.007); however, this was not the case with the other IIEF-5 subdomains. Self-assessment showed a tendency 
toward a negative correlation with the RHI value (R=−0.202, p=0.080).
Conclusions: The role of endothelial function measurement by the EndoPAT in the evaluation and management of ED patients 
remains inconclusive. However, further studies are needed to validate the role of endothelial function measurement, by the 
EndoPAT or any other device.
Key Words: Endothelium; Erectile dysfunction; Plethysmography
INTRODUCTION
　Endothelial function is known to be impaired in patients 
with chronic pathologic conditions, including coronary 
artery disease, diabetes mellitus, hypertension, obesity, 
renal failure, impaired lipid profiles, and erectile dysfunc-
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tion (ED) [1-6]. Endothelial dysfunction is of critical im-
portance as an early predictor of these vascular diseases 
[7-9]. The risk factors for cardiovascular disease (CVD) and 
ED are frequently similar, and ED is believed to be a major 
sign and independent predictor of future cardiovascular 
events in patients with CVD [10-12].
　The assessment of endothelial function is relevant for 
the etiological evaluation and follow-up of patients with 
sexual dysfunction. The pulse in the arteries of the fingers 
or the flow-mediated dilatation (FMD) of the brachial ar-
tery by manipulation of blood flow can be used to evaluate 
endothelial function. Theoretically, FMD is thought to be 
related to an increase in the shear stress experienced by 
the vessels and the release of nitric oxide [13]. This technique 
has been widely used as a tool for assessing endothelial 
dysfunction. However, the results are operator-depend-
ent, and this measurement does not reflect systemic hemo-
dynamic changes because FMD is measured only in one 
arm [14]. More recent studies have described the efficacy 
of peripheral artery tonometry (PAT) for assessing the en-
dothelial function of peripheral vessels [14,15]. The 
EndoPAT apparatus (EndoPAT 2000; Itamar Medical Ltd., 
Caesarea, Israel) was devised to overcome these prob-
lems, allowing the non-invasive measurement of vaso-
reactivity without the disadvantages of conventional mea-
suring methods. The EndoPAT plethysmographically mea-
sures changes of vascular pressure in the finger by detect-
ing arterial pulsation, and translates the signal into PAT.
　Since endothelial dysfunction is well-known to be a 
causative factor of ED, the measurement of endothelial 
function with EndoPAT could be used as a tool for assess-
ing individual erectile function in various clinical condi-
tions. Moreover, characterizing the pathophysiology and 
relationship between PAT and erectile dysfunction could 
potentially have a significant impact on patients. While 
much effort has been directed towards the evaluation of 
endothelial dysfunction in relation to CVD, data on the 
use of PAT to evaluate the role of endothelial function in 
ED are scarce. The aim of this study was to evaluate the as-
sociation of EndoPAT scores with self-reported erectile 
function according to the International Index of Erectile 
Function-5 (IIEF-5) questionnaire in an outpatient urology 
clinic.
MATERIALS AND METHODS
　The Institutional Review Board of Severance Hospital 
(Seoul, Korea) approved the study protocol. From October 
2014 to March 2015, we prospectively enrolled subjects 
who provided written informed consent to participate in 
this study after receiving detailed information about the 
study. The inclusion criteria were men over 40 years of 
age who visited our outpatient urology clinic for counsel-
ing about a urologic problem, such as lower urinary tract 
symptoms or erectile dysfunction. Patients with comorbi-
dities such as a history of pelvic surgery, uncontrolled dia-
betes mellitus, hypertension, urinary tract infection, ma-
lignancy, or any neurologic disease that could affect erec-
tile function were excluded. A total of 76 patients were en-
rolled in the study.
　All patients underwent a complete medical history (in-
cluding an assessment of their history of diabetes mellitus, 
hypertension, coronary artery obstructive disease, and 
smoking status), physical examination (height, weight, 
body mass index, waist circumference, and systolic/dia-
stolic blood pressure), urinalysis, and completed the IIEF-5 
and Sexual Encounter Profile (SEP) Q2 and Q3 ques-
tionnaires. Endothelial function was non-invasively meas-
ured with an EndoPAT 2000 device according to the man-
ufacturer’s specifications. All tests were performed in a 
specific isolated location that was quiet and kept at room 
temperature, and all subjects had fasted for at least three 
hours before the measurements were collected. Plethys-
mographic probes were placed on the index finger of each 
hand, and a blood pressure cuff was placed and inflated on 
one arm for five minutes to provoke a brief episode of 
ischemia. Release of the cuff led to an endothelium-de-
pendent dilation of the downstream vascular bed from a 
surge of blood flow. Measurements were obtained con-
tinuously during the five-minute baseline period, cuff oc-
clusion, and after cuff deflation. All data were automati-
cally recorded, and the post-occlusion to pre-occlusion ra-
tio of the PAT signal was defined as the reactive hyperemia 
index (RHI) and analyzed according to the patients’ base-
line characteristics using the accompanying EndoPAT 
software. An RHI value of less than 1.67 implies impaired 
endothelial function [14]. Analyses were conducted after 
categorizing the RHI and other risk factors as binary out-
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Table 2. Results of the IIEF-5 and SEP Q2 and Q3 question-
naires
IIEF-5 sum 11.20±6.36
IIEF-5 Q1 (erection confidence) 2.45±1.02
IIEF-5 Q2 (erection firmness) 2.12±1.46
IIEF-5 Q3 (maintenance frequency) 2.00±1.40
IIEF-5 Q4 (maintenance ability) 2.03±1.56
IIEF-5 Q5 (intercourse satisfaction) 2.61±1.78
Severity of ED
Complete ED (IIEF-5≤9) 28 (36.8)
Moderate ED (10≤IIEF-5≤13) 20 (26.3)
Mild ED (14≤IIEF-5≤17) 15 (19.7)
Normal (IIEF-5≥18) 13 (17.1)
Self-assessment
1 (normal) 15 (19.7)
2 (mild ED) 29 (38.2)
3 (moderate ED) 22 (28.9)
4 (complete ED) 10 (13.2)
SEP2 answered as “yes” 52 (68.4)
SEP3 answered as “yes” 29 (38.2)
Values are presented as mean±standard deviation or num-
ber (%).
IIEF-5: International Index of Erectile Function-5, SEP: Sexual
Encounter Profile, ED: erectile dysfunction.
Table 1. Characteristics of the study population
Variable Value
No. of patient 76
Age (yr) 62.50±8.56
Height (cm) 167.93±7.62
Weight (kg) 68.41±11.57
BMI (kg/m2) 24.30±4.17
Waist circumference (cm) 89.09±9.22
SBP (mmHg) 127.21±15.90
DBP (mmHg) 78.46±11.85
Medical history
CAOD 4 (5.3)
Hypertension 39 (51.3)
Diabetes mellitus 16 (21.1)
Dyslipidemia 28 (36.8)
Smoking history 56 (73.7)
Ex-smoker 44 (57.9)
Current smoker 12 (15.8)
Non-smoker 20 (26.3)
Marital status
Not married 1 (1.3)
Married 69 (90.9)
Divorced 3 (3.9)
Bereaved 3 (3.9)
Values are presented as number only, mean±standaed
deviation, or number (%).
BMI: body mass index, SBP: systolic blood pressure, DBP: 
diastolic blood pressure, CAOD: coronary artery obstructive 
disease.
comes and establishing correlations between the para-
meters.
　All data were analyzed using IBM SPSS ver. 20.0.0.2 
(IBM Co., Armonk, NY, USA). Statistical analyses of con-
tinuous variables were conducted using the Student’s 
t-test, one-way analysis of variance (ANOVA), the Mann- 
Whitney U-test, or the Kruskal-Wallis test. Pearson’s cor-
relation analysis was used to investigate relationships be-
tween the variables. Two-sided tests were applied, and p＜ 
0.05 were considered to indicate statistical significance.
RESULTS
　The mean patient age was 62.50±8.56 years, and the 
mean patient IIEF-5 score was 11.20±6.36. The clinical 
characteristics of the patients and details of their responses 
to the questionnaires assessing ED symptoms are shown in 
Table 1, 2.
　When the RHI was compared according to ED risk fac-
tors, it was found that the RHI was significantly lower in 
older subjects (1.48±0.38 in subjects ≥63 years of age 
vs. 1.79±0.50 in subjects ＜63 years of age, p=0.004). 
No significant differences in RHI were found according to 
age, body mass index, waist circumference, obesity, 
smoking habits, or other comorbidities (Table 3).
　Relationships between the RHI and IIEF-5 scores were 
tested (Fig. 1). When subjects were divided into four 
groups according to the severity of ED based on their total 
IIEF-5 scores, no statistically significant differences in the 
RHI were found (p=0.542 by ANOVA). No significant dif-
ferences were found in IIEF-5 scores according to RHI 
when the RHI was categorized according to the normal 
cutoff value (p=0.342 by the Student’s t-test) or quartile 
ranges (p=0.476 by ANOVA). No statistically significant 
differences in the RHI were found according to the pene-
tration success rate (SEP Q2) or the intercourse success 
rate (SEP Q3) (data not shown).
　In the correlation analyses between the RHI and each of 
the IIEF-5 subdomains (Fig. 2), the second subdomain of 
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Table 3. Comparison of the RHI according to erectile dys-
function risk factors
Variable Number RHI value p-value
Age (yr) 0.004b
＜63
≥63
41
35
1.79±0.50
1.48±0.38
BMI (kg/m2) 0.166b
＜25
≥25
51
25
1.59±0.39
1.77±0.59
WC (cm) 0.487b
＜90
≥90
47
29
1.62±0.46
1.70±0.49
Obesitya 0.507b
No
Yes
38
38
1.61±0.40
1.68±0.54
Smoking 0.699c
Non-smoker
Ex-smoker
Current smoker
20
44
12
1.71±0.45
1.64±0.52
1.56±0.32
Diabetes mellitus 0.158d
No
Yes
16
60
1.68±0.49
1.52±0.35
Hypertension 0.825b
No
Yes
37
39
1.64±0.49
1.66±0.45
Dyslipidemia 0.645b
No
Yes
48
28
1.67±0.51
1.62±0.39
Values are presented as number only or mean±standard
deviation.
RHI: reactive hyperemia index, BMI: body mass index, WC: 
waist circumference.
aBMI≥25 kg/m2, or WC≥90 cm, bStudent’s t-test, 
cKruskal-Wallis test, dMann-Whitney U-test.
IIEF-5 (erection firmness) was found to be significantly cor-
related with the RHI (R=0.309, p=0.007). However, no 
statistically significant correlations were found between 
the RHI and other IIEF-5 subdomains. Self-assessment 
scores showed a marginally significant tendency to be 
negatively correlated with RHI (R=−0.202, p=0.080).
DISCUSSION
　EndoPAT is a promising non-invasive technique for 
measuring peripheral vasodilation response, which has 
been associated with both endothelial dysfunction and 
CVD [16,17]. Subclinical and systemic inflammatory 
changes due to atherosclerosis result in endothelial dys-
function in both large and small blood vessels, and play a 
critical role in cardiovascular and peripheral vascular dis-
ease [18]. Specific changes in penile vasculature (i.e., de-
creased diameter of the cavernosal arteries along with a 
high proportion of endothelial content in the penile vas-
cular bed) can be used as a sensitive indicator of systemic 
vascular conditions [10]. Specifically, abnormal responses 
to hyperemic environments measured using PAT have 
been found to be significantly correlated with coronary 
microvascular endothelial dysfunction, as measured by 
coronary angiography [14]. As a non-invasive modality for 
evaluating both the current and future risks of CVD, the 
usefulness of PAT has been well documented in many 
publications, and it is a clinically relevant test when con-
sidering treatment plans for patients at risk for CVD. 
Marked endothelial dysfunction has been shown in pa-
tients with vasculogenic ED in comparison to non-ED pa-
tients with similar risk factors [19], and endothelial dys-
function may be an early manifestation of ED. Further-
more, since vasculogenic ED is also known as a herald of 
impending systemic CVD, the relationship between ED 
and CVD may be important for the potential early de-
tection of cardiovascular risk in ED patients.
　The presence of a close relationship between endothe-
lial dysfunction and ED has become clear, especially be-
cause endothelial dysfunction has been increasingly re-
ported to be associated with vasculogenic ED. Recently, 
advances in diagnostic technology have greatly improved 
the capability to identify the pathophysiologic profile of a 
vascular condition. One such advance, the EndoPAT 
2000 device, permits the accurate detection and quantifi-
cation of endothelial function though a PAT measure-
ment. Occlusion of the brachial artery induces endothe-
lium-mediated changes in the vascular tone, reflecting a 
downstream hyperemic response [20]. These findings are 
compared to concurrent non-endothelium-dependent 
changes in vascular tone from measurements on the con-
tralateral arm, which are used to correct for the systemic 
hemodynamic changes resulting from alteration of the au-
tonomic nervous system. Computerized calculations made 
using the EndoPAT software can provide the researcher 
with information about the change in pulse volume in re-
sponse to local ischemia and the accompanying re-
perfusion as reflected by the RHI, and about arterial stiff-
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Fig. 1. Relationships between the reactive hyperemia index (RHI) and International Index of Erectile Function-5 (IIEF-5) scores. (A) No 
statistically significant differences were observed in the RHI when subjects were divided into four groups according to the severity of 
erectile dysfunction based on their total IIEF-5 scores (p=0.542 by ANOVA). (B) No significant differences in IIEF-5 scores were observed
according to the RHI when categorized with respect to the normal cutoff value (p=0.342 by the Student’s t-test). (C) No statistically 
significant differences in IIEF-5 scores were observed according to the RHI when categorized according to quartile ranges (p=0.476 by
ANOVA). ANOVA: analysis of variance, Q: quartile, ED: erectile dysfunction.
ness as defined by the augmentation index. The test is sim-
ple and easy to perform, requiring only two finger probes 
and a blood pressure cuff, and does not have the dis-
advantage of operator dependency. The RHI, a measure of 
endothelial function, is known to be rather stable over 
time, whereas the augmentation index is known to have 
substantial intra-individual variability, limiting its value 
for clinical assessments [21]. With this in mind, we used 
the RHI to analyze relationships among PAT metrics and 
risk factors.
　In this study, we failed to show a significant difference 
in the RHI according to either categorical risk factors or the 
severity of ED. Our correlation analysis revealed that only 
the IIEF-5 Q2 was positively correlated with the RHI. 
Likewise, other subdomains, including self-assessment, 
showed poor correlations. Our results are very similar to 
those reported by Aversa et al [22]; in a small study of 70 
patients, they found no statistically significant differences 
in PAT scores between ED and non-ED groups. Interestingly, 
Vardi et al [23] measured the baseline blood flow in both 
the forearm and the penis, and calculated the correspond-
ing vascular resistance values for patients without signifi
cant systemic vasculopathy using venocclusive plethys-
mography at both the forearm and the penile levels. They 
found that the baseline blood flow of the forearm was sim-
ilar between the ED and non-ED groups, but that the blood 
flow of the penis was significantly lower, with significantly 
higher penile vascular resistance observed among patients 
with ED. This result suggested that penile, but not forearm, 
endothelial function is significantly altered in patients 
with ED in comparison to those without ED. Seager et al 
[15] also reported similar results, finding a lack of pre-
dictive correlations between PAT and color Doppler ultra-
sound parameters in men with ED. Several possible ex-
planations could exist for these results. The PAT signal can 
be altered by some comorbidities involving systemic vas-
cular disorders, such as hypertension, diabetes mellitus, 
hyperlipidemia, and other risk factors for CVD, yielding a 
low or abnormal RHI value compared to that observed in 
a healthy population [13]. Since the PAT measurement has 
primarily been validated in CVD patients, the threshold 
value for identifying endothelial dysfunction indicative of 
ED might be different from the appropriate cutoff value in 
the context of CVD. More studies are warranted to identify 
a valid threshold value specific for endothelial dysfunc-
tion in ED.
　Several confounding factors were present in the present 
study that may have contributed to the absence of correla-
tion between EndoPAT scores and ED. First, the patients 
enrolled in this study were for the most part older men 
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Fig. 2. Correlations between the reactive hyperemia index (RHI) and the International Index of Erectile Function-5 (IIEF-5) subdomains.
The second subdomain of the IIEF-5 (erection firmness) was significantly correlated with the RHI (R=0.309, p=0.007). However, no 
statistically significant correlations were found between RHI values and other IIEF-5 subdomains. Self-assessment scores showed a 
marginally significant tendency to be negatively correlated with the RHI (R=−0.202, p=0.080).
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(mean age, 62.50±8.56 years) who may have had prob-
lems with sexual activity. In our study population, 90.9% 
of subjects reported that they were married, but their mean 
overall IIEF-5 score was 11.20±6.36. Approximately 60% 
of participants were diagnosed with complete to moderate 
ED. Second, our study cohort was potentially heteroge-
neous in ways that could have affected our findings. We 
did not classify patients into subgroups according to co-
morbidities and smoking history, but several studies have 
documented improvements in endothelial dysfunction as 
a result of prolonged pharmacological interventions or 
lifestyle modifications such as smoking cessation and diet-
ary changes [24-27]. Third, no other ED risk factors were 
evaluated in the present study. We did not measure serum 
testosterone levels or perform Doppler ultrasound imag-
ing, which could have been helpful in distinguishing vas-
culogenic and non-vasculogenic ED.
　The present study is the first report on the relationship 
between EndoPAT scores and ED conducted in a real clin-
ical setting in a Korean population. The clinical usefulness 
of EndoPAT in the evaluation and management of ED ap-
pears unclear. Nevertheless, the results of this preliminary 
study indicate that more precise and well-designed studies 
are needed to evaluate the relationship between endothe-
lial function and ED.
CONCLUSIONS
　In this study, endothelial function, as measured by 
EndoPAT, was not associated with erectile function as re-
flected by overall IIEF-5 scores, but did show a significant 
correlation with scores in the IIEF-5 erection firmness 
subdomain. No consensus exists regarding whether endo-
thelial function as measured by EndoPAT should play a 
role in the management of ED patients. However, further 
studies are needed to validate the role of endothelial func-
tion measurements, by EndoPAT or any other device, in 
the evaluation and management of ED patients.
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